NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit
U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention
Avastin Improves PFS In Advanced Breast Cancer
Preoperative Drug Combo Benefits HER-2 Breast Cancer
Combination Radiation/Vaccine May Benefit Some Patients
“Inoperable” Prostate Cancer May Be Operable, Curable
Benefit Seen In Novel Drug That Treats Gleevec Resistance
NCI’s Rosenberg Confirms 2002 Immunotherapy Results
NCI-Approved Clinical Trials
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
